Rather than improving drug value and creating an efficient marketplace, the PBM industry has fueled flawed practices that harm employers and American workers. This workshop provides a roadmap for navigating the drug purchasing landscape and insight into how market trends, legislation, PBM misalignment, and scientific advancements will shape healthcare strategies of the future. Real-world case studies explore practical solutions to align PBM services with employer needs and improve employee experiences. Experts will also explain how intermediaries are inflating drug costs and blocking value from reaching employers — and what to do about it.